Press Releases

Revelar™ now provides healthcare professionals with the ability to determine how antioxidants and other treatments affect aldehyde scores

PORTLAND, OR — Pulse Health announces Revelar™ the first non-invasive device to help healthcare professionals and their patients measure aldehydes and help minimize free radical damage. Revelar is breakthrough breath technology that accurately detects and measures the presence of aldehydes, which are indicators of free radical damage in the body (research, Rapid Commun Mass Spectrum 2003).

Free radicals are molecules, present in every person, but can become unstable leading to cell damage and eventually disease. Free radical damage is also referred to as Oxidative stress or simply cell or tissue damage. Extensive scientific research has shown that an overabundance of free radicals is associated with many degenerative diseases including heart and lung disease, cancer, and premature aging (research, American Journal of Epidemiology 2001). Factors that may contribute to production of free radicals include diet, activity level, stress, chemicals, pollutants and other factors.

Revelar™ from Pulse Health is a breakthrough in accurately measuring the indications that can lead to heart disease, cancer and early aging.

PORTLAND, OR — Revelar™, the first device to measure aldehydes — known indicators of free radical damage — in a simple breath test, will immediately receive a $244,479 award under IRS grant 48D for qualifying therapeutic discovery projects. The actual certification was for $488,959 based on Revelar’s capability to accurately measure a patient’s free radical damage through the aldehydes present in their breath.

Portland, Ore., September 21, 2010 — The Oregon Entrepreneurs Network (OEN), today announced the winners of the 2011 OEN Tom Holce Entrepreneurship Awards.